Most bought healthcare stocks in Q3 2019
See which Healthcare stocks institutional investors increased the most in Q3 2019, measured as net growth in reported share positions from Q2 2019 into Q3 2019. Notable additions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), TEVA PHARMACEUTICAL-SP ADR (TEVA), STEREOTAXIS INC (STXS), GILEAD SCIENCES INC (GILD). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 12,509,689 | $1.09B | 2 | 4 | 4 | 0 | 12 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 5,165,791 | -$146.89M | 0 | 3 | 1 | 0 | 6 |
| STXS | STEREOTAXIS INC | 4,689,885 | $16.46M | 2 | 0 | 0 | 0 | 2 |
| GILD | GILEAD SCIENCES INC | 3,593,665 | $52.82M | 2 | 7 | 1 | 0 | 10 |
| GH | GUARDANT HEALTH INC | 3,195,190 | $202.28M | 2 | 1 | 0 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | 2,697,385 | $115.23M | 0 | 4 | 9 | 0 | 17 |
| PRGO | Perrigo Company PLC | 2,382,292 | $169.98M | 1 | 0 | 3 | 0 | 4 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 2,274,606 | $132.50M | 0 | 2 | 0 | 0 | 2 |
| NVST | ENVISTA HOLDINGS CORP | 1,948,263 | $54.32M | 2 | 0 | 0 | 0 | 2 |
| ABBV | ABBVIE INC | 1,938,329 | $164.30M | 1 | 4 | 2 | 1 | 9 |
| MOH | MOLINA HEALTHCARE INC | 1,887,111 | $78.99M | 1 | 1 | 0 | 0 | 2 |
| BHC | BAUSCH HEALTH COS INC | 1,884,003 | -$50.75M | 0 | 1 | 1 | 1 | 4 |
| MRK | MERCK & CO. INC. | 1,737,913 | $149.04M | 0 | 5 | 7 | 1 | 15 |
| BKD | BROOKDALE SENIOR LIVING INC | 1,605,630 | $16.38M | 0 | 1 | 0 | 0 | 1 |
| HUM | HUMANA INC | 1,584,570 | $375.89M | 1 | 1 | 1 | 0 | 3 |
| CVS | CVS HEALTH CORP | 1,545,159 | $431.92M | 1 | 7 | 2 | 0 | 11 |
| BIIB | BIOGEN INC | 1,389,636 | $319.93M | 1 | 2 | 2 | 0 | 6 |
| EXEL | EXELIXIS INC | 1,380,320 | -$25.22M | 0 | 1 | 0 | 1 | 1 |
| INVA | INNOVIVA INC | 1,357,779 | -$15.50M | 0 | 2 | 0 | 0 | 2 |
| ELV | ELEVANCE HEALTH INC | 1,310,074 | -$198.49M | 2 | 3 | 3 | 1 | 10 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,269,136 | $594.00K | 0 | 1 | 0 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1,217,000 | $8.63M | 0 | 1 | 0 | 0 | 1 |
| CI | THE CIGNA GROUP | 1,159,511 | $79.76M | 0 | 2 | 0 | 1 | 3 |
| ALKS | ALKERMES PLC | 950,622 | $6.58M | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 933,700 | $29.89M | 0 | 1 | 0 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | 932,627 | $65.16M | 1 | 2 | 2 | 1 | 5 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 908,160 | $9.24M | 0 | 1 | 2 | 0 | 3 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 756,797 | $3.76M | 1 | 0 | 0 | 0 | 2 |
| ENZ | ENZO BIOCHEM INC | 751,228 | $3.53M | 0 | 2 | 0 | 0 | 2 |
| HOLX | HOLOGIC INC | 743,175 | $77.56M | 0 | 2 | 1 | 1 | 3 |
| AMGN | AMGEN INC | 682,485 | $171.25M | 0 | 2 | 3 | 0 | 7 |
| ZTS | ZOETIS INC | 630,935 | $262.42M | 0 | 4 | 2 | 0 | 6 |
| GMAB | GENMAB A/S -SP ADR | 609,382 | $13.57M | 1 | 1 | 0 | 0 | 2 |
| BSX | BOSTON SCIENTIFIC CORP | 599,771 | -$10.06M | 0 | 1 | 3 | 1 | 4 |
| ILMN | ILLUMINA INC | 594,816 | $48.02M | 1 | 2 | 0 | 1 | 3 |
| CMRX | CHIMERIX INC | 539,458 | -$2.20M | 0 | 1 | 0 | 0 | 1 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 503,100 | $5.37M | 0 | 1 | 0 | 0 | 1 |
| MRSN | MERSANA THERAPEUTICS INC | 500,705 | $134.00K | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 487,407 | -$27.90M | 0 | 3 | 0 | 0 | 3 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 484,369 | $1.84M | 0 | 2 | 0 | 0 | 2 |
| PFE | PFIZER INC | 470,878 | -$140.60M | 0 | 6 | 5 | 2 | 11 |
| OMI | OWENS & MINOR INC | 426,484 | $4.63M | 0 | 1 | 0 | 0 | 1 |
| ATYR | ATYR PHARMA INC | 422,903 | $1.48M | 2 | 0 | 0 | 0 | 2 |
| PINC | PREMIER INC-CLASS A | 418,550 | -$22.97M | 0 | 2 | 0 | 0 | 2 |
| VNDA | VANDA PHARMACEUTICALS INC | 410,290 | $3.18M | 0 | 1 | 0 | 0 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 395,700 | $18.36M | 0 | 1 | 0 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 381,659 | -$671.00K | 0 | 1 | 0 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 377,804 | $48.99M | 0 | 1 | 0 | 1 | 1 |
| VREX | VAREX IMAGING CORP | 369,960 | $7.91M | 0 | 2 | 0 | 0 | 2 |
| VYGR | VOYAGER THERAPEUTICS INC | 343,100 | -$1.40M | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q3 2019
What are the most bought Healthcare stocks in Q3 2019?
The most bought healthcare stocks in Q3 2019 are those with the largest increase in reported share counts across institutional investors compared to Q2 2019, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2019?
Among filers in this sector, net additions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), TEVA PHARMACEUTICAL-SP ADR (TEVA), STEREOTAXIS INC (STXS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2019).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.